SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001746473-23-000074
Filing Date
2023-11-09
Accepted
2023-11-09 16:15:08
Documents
80
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q plrx-20230930.htm   iXBRL 10-Q 1364305
2 EX-31.1 CEO CERTIFICATION plrx-20230930xex311.htm EX-31.1 10447
3 EX-31.2 CFO CERTIFICATION plrx-20230930xex312.htm EX-31.2 10415
4 EX-32.1 CEO AND CFO CERTIFICATION plrx-20230930xex321.htm EX-32.1 7301
  Complete submission text file 0001746473-23-000074.txt   6292499

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT plrx-20230930.xsd EX-101.SCH 50772
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT plrx-20230930_cal.xml EX-101.CAL 56902
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT plrx-20230930_def.xml EX-101.DEF 229341
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT plrx-20230930_lab.xml EX-101.LAB 555064
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT plrx-20230930_pre.xml EX-101.PRE 390082
74 EXTRACTED XBRL INSTANCE DOCUMENT plrx-20230930_htm.xml XML 690347
Mailing Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080 650-481-6770
PLIANT THERAPEUTICS, INC. (Filer) CIK: 0001746473 (see all company filings)

IRS No.: 474272481 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39303 | Film No.: 231392603
SIC: 2834 Pharmaceutical Preparations